Wee Edmund, Denton Eve, Daffy John
Department of Medicine St Vincent's Hospital Melbourne Melbourne Victoria Australia.
Department of Respiratory and Sleep Medicine Alfred Hospital Melbourne Victoria Australia.
Respirol Case Rep. 2015 Sep 22;3(4):135-7. doi: 10.1002/rcr2.126. eCollection 2015 Dec.
Mycobacterium tuberculosis (TB) presenting with pericardial disease complicated by cardiac tamponade is rare in the developed world, although it occurs more frequently in the context of immunosuppression. In this report, a 74-year-old man on methotrexate for rheumatoid arthritis presented with fever, productive cough and cough-induced syncope. During his admission, he developed clinical signs of cardiac tamponade confirmed on an echocardiogram, which showed a massive pericardial effusion. He was treated with an urgent pericardiocentesis and a pericardial window. Subsequently, TB polymerase chain reaction of pericardial fluid unexpectedly returned positive, and he was commenced on standard quadruple therapy for TB, as well as high-dose prednisolone. Notably, the patient did not have a history suggestive of previous TB exposure, and no screening investigations had been performed prior to initiation of methotrexate. This case highlights the importance of TB screening prior to immunosuppressive therapy, even in populations considered low risk for latent disease.
在发达国家,表现为心包疾病并伴有心脏压塞的结核分枝杆菌(TB)较为罕见,尽管在免疫抑制情况下其发生率更高。在本报告中,一名因类风湿关节炎服用甲氨蝶呤的74岁男性出现发热、咳痰和咳嗽诱发的晕厥。住院期间,他出现了心脏压塞的临床体征,超声心动图证实有大量心包积液。他接受了紧急心包穿刺和心包开窗术治疗。随后,心包液的结核聚合酶链反应意外呈阳性,他开始接受标准的四联抗结核治疗以及大剂量泼尼松龙治疗。值得注意的是,该患者既往无提示曾接触过结核的病史,在开始使用甲氨蝶呤之前也未进行过筛查。这个病例凸显了在免疫抑制治疗前进行结核筛查的重要性,即使是在被认为潜伏疾病风险较低的人群中。